Health care disparities among octogenarians and nonagenarians with stage III lung cancer-Reference-Cited by-同舟云学术

Health care disparities among octogenarians and nonagenarians with stage III lung cancer

Published:2018-01-08 Issue:4 Volume:124 Page:775-784
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Cassidy Richard J.¹^ORCID,Zhang Xinyan²,Switchenko Jeffrey M.²,Patel Pretesh R.¹,Shelton Joseph W.¹,Tian Sibo¹,Nanda Ronica H.³,Steuer Conor E.⁴,Pillai Rathi N.⁴,Owonikoko Taofeek K.⁴,Ramalingam Suresh S.⁴^ORCID,Fernandez Felix G.⁵,Force Seth D.⁵,Gillespie Theresa W.⁶,Curran Walter J.¹,Higgins Kristin A.¹

Affiliation:

1. Department of Radiation Oncology, Winship Cancer Institute; Emory University; Atlanta Georgia

2. Department of Biostatistics and Bioinformatics, Winship Cancer Institute; Emory University; Atlanta Georgia

3. University of Florida Health Proton Therapy Institute; Jacksonville Florida

4. Department of Medical Oncology, Winship Cancer Institute; Emory University; Atlanta Georgia

5. Department of Thoracic Surgery, Winship Cancer Institute; Emory University; Atlanta Georgia

6. Department of Surgery, Winship Cancer Institute; Emory University; Atlanta Georgia

Funder

Biostatistics and Bioinformatics Shared Resource of Winship Cancer Institute of Emory University

Foundation for the National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference40 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin.,2016

2. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410;Curran;J Natl Cancer Inst.,2011

3. Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients;Auperin;Ann Oncol.,2006

4. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study;Zatloukal;Lung Cancer.,2004

5. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study;Bradley;Lancet Oncol.,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiomics-Based Feature Extraction and Selection for the Prediction of Lung Cancer Survival;International Journal of Molecular Sciences;2024-03-25

2. Lung cancer outcomes in the elderly: potential disparity in screening;European Journal of Cardio-Thoracic Surgery;2024-03-01

3. Treatment at Twilight: An Analysis of Therapy Patterns and Outcomes in Adults 80 Years and Older With Advanced or Metastatic NSCLC;JTO Clinical and Research Reports;2023-10

4. Disparities in Lung Cancer: A Targeted Literature Review Examining Lung Cancer Screening, Diagnosis, Treatment, and Survival Outcomes in the United States;Journal of Racial and Ethnic Health Disparities;2023-05-19

5. Is immunotherapy at reduced dose and radiotherapy for older patients with locally advanced non-small lung cancer feasible?—a narrative review by the international geriatric radiotherapy group;Translational Cancer Research;2022-09